(IBTI) iShares iBonds Dec 2028 - Ratings and Ratios
Treasury Bonds, 2028 Maturity, US Government, Fixed Income
| Risk via 10d forecast | |
|---|---|
| Volatility | 1.64% |
| Value at Risk 5%th | 2.57% |
| Relative Tail Risk | -4.69% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.77 |
| Alpha | 2.23 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.549 |
| Beta | -0.032 |
| Beta Downside | -0.042 |
| Drawdowns 3y | |
|---|---|
| Max DD | 5.42% |
| Mean DD | 1.37% |
| Median DD | 0.99% |
Description: IBTI iShares iBonds Dec 2028 November 17, 2025
The iShares iBonds Dec 2028 Term Treasury ETF (IBTI) seeks to track an index of U.S. Treasury securities that all mature in 2028. At least 80 % of its assets must be invested in the index’s component securities, and a minimum of 90 % must be held in Treasuries that BlackRock’s BFA team believes will best replicate the index’s performance.
Key metrics (as of the latest filing) include an expense ratio of 0.05 %, an average effective duration of roughly 5.9 years, and a current weighted-average yield near 4.2 %. The fund’s performance is highly sensitive to Federal Reserve policy and inflation expectations, since changes in short-term rates directly affect the price of the 2028-maturing Treasuries that dominate its holdings.
If you want a more granular view of IBTI’s risk-adjusted returns and scenario analysis, consider checking out ValueRay’s data tools for deeper insight.
IBTI ETF Overview
| Market Cap in USD | 1,236m |
| Category | Target Maturity |
| TER | 0.07% |
| IPO / Inception | 2020-02-25 |
| Return 12m vs S&P 500 | -5.33% |
| Analyst Rating | - |
IBTI Dividends
| Metric | Value |
|---|---|
| Dividend Yield | 3.86% |
| Yield on Cost 5y | 3.75% |
| Yield CAGR 5y | 55.74% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
IBTI Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | 4.24% |
| CAGR/Max DD Calmar Ratio | 0.78 |
| CAGR/Mean DD Pain Ratio | 3.09 |
| Current Volume | 226.9k |
| Average Volume | 226.1k |
What is the price of IBTI shares?
Over the past week, the price has changed by +0.31%, over one month by +0.12%, over three months by +1.59% and over the past year by +6.37%.
Is IBTI a buy, sell or hold?
What are the forecasts/targets for the IBTI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 23.9 | 6.6% |
IBTI Fundamental Data Overview November 19, 2025
Beta = 0.68
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.24b USD (1.24b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 1.24b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.24b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 5.90% (E(1.24b)/V(1.24b) * Re(5.90%) + (debt-free company))
Discount Rate = 5.90% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for IBTI ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle